Hendershot Investments Inc. Abb Vie Inc. Transaction History

Hendershot Investments Inc.

$684 Million
Q2 2024

A detailed history of Hendershot Investments Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Hendershot Investments Inc. holds 7,652 shares of ABBV stock, worth $1.48 Million. This represents 0.19% of its overall portfolio holdings.

Number of Shares

7,652

Previous 7,652 -0.0%

Holding current value

$1.48 Million

Previous $1.39 Million 5.81%

% of portfolio

0.19%

Previous 0.2%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 22, 2024	SELL	$159.82 - $182.1 $47,946 - $54,630	-300 Reduced 3.77%	7,652 $1.39 Million
Q3 2023 Oct 23, 2023	SELL	$133.59 - $154.65 $74,543 - $86,294	-558 Reduced 6.56%	7,952 $1.19 Million
Q1 2023 Apr 25, 2023	SELL	$144.61 - $166.54 $150,394 - $173,201	-1,040 Reduced 10.89%	8,510 $1.36 Million
Q4 2022 Jan 24, 2023	BUY	$138.31 - $165.87 $3,872 - $4,644	28 Added 0.29%	9,550 $0
Q3 2022 Nov 01, 2022	SELL	$134.21 - $153.93 $1.18 Million - $1.36 Million	-8,825 Reduced 48.1%	9,522 $1.28 Million
Q2 2022 Jul 22, 2022	SELL	$137.62 - $174.96 $11,697 - $14,871	-85 Reduced 0.46%	18,347 $2.81 Million
Q4 2021 Feb 04, 2022	BUY	$107.43 - $135.93 $1.98 Million - $2.51 Million	18,432 New	18,432 $2.5 Million
Q3 2019 Oct 29, 2019	SELL	$62.98 - $75.72 $9.9 Million - $11.9 Million	-157,156 Closed	0 $0
Q2 2019 Jul 31, 2019	SELL	$65.7 - $83.98 $32,850 - $41,990	-500 Reduced 0.32%	157,156 $11.4 Million
Q1 2019 May 07, 2019	BUY	$77.14 - $90.79 $279,246 - $328,659	3,620 Added 2.35%	157,656 $12.7 Million
Q4 2018 Jan 29, 2019	BUY	$77.85 - $96.01 $262,120 - $323,265	3,367 Added 2.23%	154,036 $14.2 Million
Q3 2018 Oct 17, 2018	BUY	$88.91 - $98.84 $360,707 - $400,993	4,057 Added 2.77%	150,669 $14.3 Million
Q2 2018 Jul 31, 2018	BUY	$89.78 - $106.23 $197,067 - $233,174	2,195 Added 1.52%	146,612 $13.6 Million
Q1 2018 Apr 17, 2018	SELL	$92.01 - $123.21 $258,548 - $346,220	-2,810 Reduced 1.91%	144,417 $13.7 Million
Q4 2017 Jan 22, 2018	SELL	$89.56 - $98.21 $141,057 - $154,680	-1,575 Reduced 1.06%	147,227 $14.2 Million
Q3 2017 Oct 31, 2017	BUY	$69.85 - $89.22 $10.4 Million - $13.3 Million	148,802	148,802 $13.2 Million

Others Institutions Holding ABBV

# of Institutions

3,689

Shares Held

1.27B

Call Options Held

13M

Put Options Held

9.79M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $342B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hendershot Investments Inc., based on Form 13F filings with the SEC.

News

Stay updated on Hendershot Investments Inc. with notifications on news.

Account

Hendershot Investments Inc. Abb Vie Inc. Transaction History